Neurobiological Technologies, Inc.
NTII - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.7K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2,702.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0.12 |
| Beta | 7.38 |
| Outstanding Shares | 26,930,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Neurobiological Technologies, Inc.
4 employees
CEO: John B. Stuppin
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the develop...